Elms Steve's Form 4 filing
Adma Biologics, Inc. (ADMA) · filed Mar 19, 2024
- Accession no.
- 0001140361-24-014226
- Filed
- Mar 19, 2024
- Trade date
- Mar 18-19, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.80M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Elms SteveCIK 0001250195 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2024 | Common Stock | SSaleDisposed | −49,887 | $6.01 | −$299,820.87 | 2,527,500 | Indirect | |
| Mar 19, 2024 | Common Stock | SSaleDisposed | −411,829 | $6.08 | −$2,503,920.32 | 2,115,671 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.